Re: Indirect Cost (F&A) Rates Charged on Clinical Trials Bivona and Kleinberg BML 21 Feb 2008 13:12 EST
We try to negotiate a 35% indirect rate for clinical trials, which is different from our federally-approved rate. _________________________________ Alicia Bivona & Jessica Kleinberg, CRA Office of Sponsored Programs Health Research, Inc. One University Place Rensselaer, NY 12144-3447 Phone: (518) 431-1264 Fax: (518) 431-1234 Email: xxxxxx@healthresearch.org "Bloomberg, Robert" <xxxxxx@TUFTS To -NEMC.ORG> xxxxxx@hrinet.org Sent by: Research cc Administration List Subject <xxxxxx@hrinet. Re: [RESADM-L] Indirect Cost (F&A) org> Rates Charged on Clinical Trials 02/21/2008 12:38 PM Please respond to Research Administration Discussion List <xxxxxx@hrinet. org> In a related question, I would be interested in knowing if anyone is charging a different rate for clinical trials than they charge for grants. Thanks. -----Original Message----- From: Research Administration List [mailto:xxxxxx@hrinet.org]On Behalf Of Hudobenko,Paul F. Sent: Thursday, February 21, 2008 12:16 PM To: xxxxxx@hrinet.org Subject: [RESADM-L] Indirect Cost (F&A) Rates Charged on Clinical Trials We are considering revising the indirect cost rate that we charge to clinical trials. I would appreciate finding out what rates other institutions impose on these projects. Also, if anyone has recently changed their rate, has it had an effect on the number of trials and/or dollar volume of clinical trial funds received for your institution? All responses will be appreciated. You may respond off-list if you wish to my email address below. Thank you. Paul Hudobenko University of Connecticut Health Center xxxxxx@adp.uchc.edu ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ====================================================================== IMPORTANT NOTICE: This e-mail and any attachments may contain confidential or sensitive information which is, or may be, legally privileged or otherwise protected by law from further disclosure. It is intended only for the addressee. If you received this in error or from someone who was not authorized to send it to you, please do not distribute, copy or use it or any attachments. Please notify the sender immediately by reply e-mail and delete this from your system. Thank you for your cooperation. ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================